Artialis

Artialis is a specialized Contract Research and Development Organization (CRDO) based in Liège, Belgium, providing integrated biotesting, preclinical, and clinical services to companies developing therapeutics, supplements, and vaccines for age-related diseases. With over 14 years of industry experience and a track record of 142 completed projects, the company leverages deep expertise in osteoarthritis, rheumatoid arthritis, and broader musculoskeletal and neurodegenerative conditions to guide client products from concept to market. Its business model is entirely service-based, generating revenue from R&D partnerships, and it distinguishes itself through a flexible, high-touch approach and a strong publication record in healthy aging research.

Integrated service platform offering biotesting, preclinical, and clinical research services with specialized expertise in disease models and biomarker development for age-related conditions.

Artialis competes in the fragmented Contract Research Organization market, facing competition from large, full-service global CROs (e.g., IQVIA, PPD) and smaller niche players specializing in specific therapeutic areas. Its differentiation is its focused expertise on the biology of aging and age-related diseases, particularly musculoskeletal conditions, offering a integrated, high-touch service model compared to the more transactional approach of larger competitors.